Share-Based Compensation

12 Months Ended

Feb. 01, 2025

Feb. 03, 2024

Share-Based Payment Arrangement [Abstract]

Equity Incentive Plan

Pursuant to the Company's 2022 Equity Incentive Plan (the “Plan”), the Company’s Board of Directors may grant stock options, restricted shares and restricted stock units to officers, directors, key crew and professional service providers. The Plan allows for the issuance of up to a total of 4.3 million shares under the Plan. As of February 1, 2025, approximately 3.2 million stock options, restricted shares, or restricted stock units were available for grant.

Common Stock Options

All stock options have a term not greater than ten years. Stock options vest and become exercisable in whole or in part, in accordance with vesting conditions set by the Company’s Board of Directors. Options granted to date generally vest over four years from the date of grant.

Stock option activity under the Plan was as follows:


	Options outstanding	Weighted average exercise price		Weighted average remaining contractual term




























Balance as of January 29, 2022	39,763	$	34.48	2.3


Exercised	(21,737)	34.11
Balance as of January 28, 2023	18,026	34.92		1.8

Forfeited	(100)	41.67
Exercised	(7,800)	36.70
Balance as of February 3, 2024	10,126	33.48		1.6


Exercised	(10,126)	33.48
Balance as of February 1, 2025	—			—
Exercisable as of February 1, 2025	—			—

The fair value of each option award granted to crew, including outside directors, is estimated on the date of grant using the Black-Scholes option-pricing model. The Company did not grant any stock options in fiscal 2024, fiscal 2023 and fiscal 2022.

The Company uses the simplified method to estimate the expected term of the option. The expected volatility incorporates historical and implied volatility of similar entities whose share prices are publicly available. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The total intrinsic value of stock options exercised during fiscal 2024, fiscal 2023 and fiscal 2022 was $0.6 million, $1.1 million and $3.1 million, respectively. There were no stock options outstanding and exercisable as of February 1, 2025. In fiscal 2024, fiscal 2023 and fiscal 2022, the Company received cash from the exercise of options of $0.3 million, $0.3 million and $0.8 million, respectively. Upon option exercise, the Company issued new shares of common stock.